Skip to main navigation
Skip to search
Skip to main content
Bar-Ilan University Home
Help & FAQ
Link opens in a new tab
Search content at Bar-Ilan University
Home
Researchers
Organisations
Research output
Prizes
Student theses
Courses
Activities
Projects
Press/Media
Datasets
Equipment
Coexistent solid malignancies in pemphigus a population-based study
Khalaf Kridin
, Shira Zelber-Sagi
, Doron Comaneshter
, Arnon D. Cohen
Rambam Health Care Campus
University of Haifa
Clalit Health Services
Ben-Gurion University of the Negev
Research output
:
Contribution to journal
›
Article
›
peer-review
37
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Coexistent solid malignancies in pemphigus a population-based study'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Population-based Study
100%
Solid Malignancies
100%
Pemphigus
100%
Healthcare
18%
Odds Ratio
18%
Malignancy
18%
Esophageal Cancer
18%
Laryngeal Cancer
18%
Sensitivity Analysis
9%
Israel
9%
Hematological Malignancies
9%
Risk Factors
9%
T-test
9%
Alcohol Abuse
9%
Esophagus
9%
Logistic Regression Model
9%
Multivariate Analysis
9%
Health Care Services
9%
Healthcare Professionals
9%
Comorbidity
9%
Comorbid
9%
Large Cohort
9%
Computerized Database
9%
Community Clinics
9%
Confounding Factors
9%
Specific Risk
9%
Immunosuppressive Therapy
9%
Gastroesophageal Reflux Disease
9%
Rituximab
9%
Corticosteroids
9%
General Community
9%
Age at Presentation
9%
Underutilization
9%
Public Healthcare
9%
Univariate Analysis
9%
Referral Center
9%
Pemphigus Vulgaris
9%
Pemphigus Foliaceus
9%
Primary Care Centers
9%
Medicine and Dentistry
Cancer
100%
Pemphigus
100%
Prevalence
18%
Health Care
18%
Odds Ratio
18%
Esophageal Cancer
18%
Laryngeal Cancer
18%
Public Health
9%
Logistic Regression Analysis
9%
Student T Test
9%
Cross Sectional Study
9%
Primary Health Care
9%
Patient Referral
9%
Health Service
9%
Drug Therapy
9%
Multivariate Analysis
9%
Observational Study
9%
Immunosuppressive Treatment
9%
Gastroesophageal Reflux
9%
Larynx
9%
Rituximab
9%
Health Care Provider
9%
Univariate Analysis
9%
Pemphigus vulgaris
9%
Esophagus
9%
Pemphigus foliaceus
9%
Immunosuppressant
9%